A new first-aid method of treating carbon monoxide poisoning could prevent brain damage in patients by delivering more oxygen to the brain than the standard treatment, according to a study by physicians at the Toronto General Hospital, University Health Network (UHN).
The study is published in the December issue of the U.S. based and peer-reviewed journal Annals of Emergency Medicine. The researchers, led by Dr. Josh Rucker, a Toronto General Hospital research fellow and resident in the Anesthesiology training program at the University of Toronto, studied 14 subjects who were exposed to low levels of carbon monoxide (resulting in blood levels about equal to those in heavy smokers) on two occasions in order to simulate conditions during carbon monoxide poisoning.
After each exposure, which lasted one hour, the participants were given one of two "test treatments": the standard treatment of 100% oxygen, or the new method consisting of a mixture of mostly oxygen and some carbon dioxide. Each participant received both test treatments in random order. Researchers then monitored the amount of oxygen in the blood and the blood flow to the brain during exposure to carbon monoxide and during the test treatments.
"These results are intriguing," said Dr. Fisher, an anesthesiologist at Toronto General Hospital, University Health Network, Associate Professor in the Faculty of Medicine at the University of Toronto and a senior author of the study. "Most doctors believe that giving patients oxygen is like giving them chicken soup -- it cant hurt. But, in fact, we find that treating carbon monoxide-exposed participants with pure oxygen actually limits the amount of oxygen that gets to their brains. That is worrisome."
"If severely poisoned patients respond like our test subjects, this new first-aid treatment may decrease the extent of brain damage in survivors," added Dr. Joseph Fisher.
CARBON MONOXIDE POISONING
The study was supported, in part, by the Department of Anesthesia, University Health Network and the University of Toronto, and the Tobi and Ted Bekhor Foundation.
The Toronto General Hospital is a partner in University Health Network, along with Toronto Western and Princess Margaret Hospitals. The scope of research and complexity of cases at Toronto General Hospital has made it a national and international source for discovery, education and patient care. It has one of the largest hospital-based research programs in Canada, with major research projects in cardiology, transplantation, surgical innovation, infectious diseases, and genomic medicine. Toronto General Hospital is a teaching hospital affiliated with the University of Toronto.
To schedule an interview with Dr. Josh Rucker or Dr. Joseph Fisher, please contact:
Toronto General Hospital, University Health Network
Marlene de Chellis | EurekAlert!
New malaria analysis method reveals disease severity in minutes
14.08.2017 | University of British Columbia
New type of blood cells work as indicators of autoimmunity
14.08.2017 | Instituto de Medicina Molecular
Whether you call it effervescent, fizzy, or sparkling, carbonated water is making a comeback as a beverage. Aside from quenching thirst, researchers at the University of Illinois at Urbana-Champaign have discovered a new use for these "bubbly" concoctions that will have major impact on the manufacturer of the world's thinnest, flattest, and one most useful materials -- graphene.
As graphene's popularity grows as an advanced "wonder" material, the speed and quality at which it can be manufactured will be paramount. With that in mind,...
Physicists at the University of Bonn have managed to create optical hollows and more complex patterns into which the light of a Bose-Einstein condensate flows. The creation of such highly low-loss structures for light is a prerequisite for complex light circuits, such as for quantum information processing for a new generation of computers. The researchers are now presenting their results in the journal Nature Photonics.
Light particles (photons) occur as tiny, indivisible portions. Many thousands of these light portions can be merged to form a single super-photon if they are...
For the first time, scientists have shown that circular RNA is linked to brain function. When a RNA molecule called Cdr1as was deleted from the genome of mice, the animals had problems filtering out unnecessary information – like patients suffering from neuropsychiatric disorders.
While hundreds of circular RNAs (circRNAs) are abundant in mammalian brains, one big question has remained unanswered: What are they actually good for? In the...
An experimental small satellite has successfully collected and delivered data on a key measurement for predicting changes in Earth's climate.
The Radiometer Assessment using Vertically Aligned Nanotubes (RAVAN) CubeSat was launched into low-Earth orbit on Nov. 11, 2016, in order to test new...
A study led by scientists of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science in Hamburg presents evidence of the coexistence of superconductivity and “charge-density-waves” in compounds of the poorly-studied family of bismuthates. This observation opens up new perspectives for a deeper understanding of the phenomenon of high-temperature superconductivity, a topic which is at the core of condensed matter research since more than 30 years. The paper by Nicoletti et al has been published in the PNAS.
Since the beginning of the 20th century, superconductivity had been observed in some metals at temperatures only a few degrees above the absolute zero (minus...
16.08.2017 | Event News
04.08.2017 | Event News
26.07.2017 | Event News
18.08.2017 | Life Sciences
18.08.2017 | Physics and Astronomy
18.08.2017 | Materials Sciences